Home › Therapeutic areas › Ophthalmology › Inherited Retinal Disease

Inherited Retinal Disease (5 companies)

Companies with an active program in Inherited Retinal Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
KPRX Kiora Pharmaceuticals Ophthalmology Rare 1 Phase 3 $4.1M 4
LCTX Lineage Cell Therapeutics MetabolicNeurology+1 Rare 1 Phase 2 $207M 13
MGTX MeiraGTx ImmunologyMetabolic+2 Rare 2 Phase 3 $827M 16
OCGN Ocugen Infectious DiseaseOphthalmology Rare 2 Phase 3 $257M 12
IRD Opus Genetics Ophthalmology Rare 6 Approved $391M 12